Embla Medical hf 2024 IR
The report highlights Embla Medical's successful transition to its new parent organization name and the strategic acquisition of Fior & Gentz, marking its expansion into neuro orthotics. Financially, the company achieved record sales of USD 855 million with 6% organic growth and a 20% EBITDA margin. On sustainability, Embla Medical received validation from the Science Based Targets initiative (SBTi) for its emissions reduction targets and reduced its emissions intensity by 2% compared to the previous year. Additionally, the company prepared for the Corporate Sustainability Reporting Directive (CSRD) by conducting a Double Materiality Assessment and aligning its disclosures with the European Sustainability Reporting Standards (ESRS).
Company: Embla Medical hf
Sector: Health Care
Country: Iceland
Year: 2024
Type: IR
Pages: 137
Embla Medical hf
Annual Report
The report highlights Embla Medical's successful transition to its new parent organization name and the strategic acquisition of Fior & Gentz, marking its expansion into neuro orthotics. Financially, the company achieved record sales of USD 855 million with 6% organic growth and a 20% EBITDA margin. On sustainability, Embla Medical received validation from the Science Based Targets initiative (SBTi) for its emissions reduction targets and reduced its emissions intensity by 2% compared to the previous year. Additionally, the company prepared for the Corporate Sustainability Reporting Directive (CSRD) by conducting a Double Materiality Assessment and aligning its disclosures with the European Sustainability Reporting Standards (ESRS).
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees